Category: Emerging MarketsSyndicate content

India considers price cap on medical devices

September 22, 2014 by Brian Johnson

India mulls instituting a maximum retail price cap on medical devices in the wake of price gouging allegations against some of medtech's largest players.

YYmeta

Indian regulators may impose price control measures on such medical devices as stents, catheters and implants in response to allegations of price gouging and bribery, according to a report in the Business Standard.

India's health ministry and department of pharamaceuticals are considering a maximum retail price cap under the National Pharmaceutical Pricing Authority, which monitors the price of 348 medicines deemed essential, the Indian newspaper reported.

Indian media accuse Medtronic, Abbott, J&J of price-hikes, bribery

September 16, 2014 by Arezu Sarvestani

Media reports in India claim that some of medtech's biggest companies are looking the other way when their Indian distributors hike prices and bribe doctors to use their drug-eluting stents.

India's news cries price hiking, bribery for Medtronic, Abbott, J&J stents

Some of medtech's biggest players are getting a beating in the Indian media, where reports this week accused them of turning a blind eye to unethical behavior from their distributors in the country.

Abbott puts $60M in Malaysia

September 11, 2014 by Arezu Sarvestani

Abbott Labs pours $60 million into a new manufacturing plant in Malaysia's Kulim Hi-Tech Park.

Abbott puts $60M in Malaysia

Chicago healthcare giant Abbott (NYSE:ABT) is preparing to open a new manufacturing facility and add 500 new employees in Malaysia, according to local reports.

Navidea eyes China with partnership for Lymphoseek imaging agent

September 4, 2014 by Arezu Sarvestani

Ohio-based Navidea Biopharmaceuticals allies with a Chinese drug group to pursue regulatory approval and prepare distribution in the emerging market.

Navidea eyes China with partnership for Lymphoseek radiopharmaceutical

Navidea Biopharmaceuticals (NYSE:NAVB) is preparing major moves in China with a new alliance that aims to bring its Lymphoseek imaging agent to the country.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp